Reshma Kewalramani

Track

Insider profile

Currently holds a position at Vertex Pharmaceuticals Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Vertex Pharmaceuticals Inc April 1, 2020 -
Executive Vice President - Global Medicines Development and Medical Affairs, Chief Medical Officer Vertex Pharmaceuticals Inc April 1, 2018 - April 1, 2020
Reshma Kewalramani's trades of Knowledge Marine & Engineering Works Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-01
B Purchase
75,118
95.71
₹1,905,325 		75,118 95.71 ₹1,905,325
2026-03-03 2026-02-27
PlS Planned sale
8,487 +13.0%
323.29
US$2,236,600 		8,487 +13.0% 323.29 US$2,236,600
2026-03-03 2026-02-27
PlS Planned sale
98,995 -37.5%
339.47
US$2,758,388 		98,995 -37.5% 339.47 US$2,758,388
2026-03-03 2026-02-27
PlS Planned sale
15,580 -12.8%
495.38
US$7,718,020 		15,580 -12.8% 495.38 US$7,718,020
2026-03-03 2026-02-27
PlS Planned sale
3,498 -2.8%
494.33
US$1,729,166 		3,498 -2.8% 494.33 US$1,729,166
2026-03-03 2026-02-27
PlS Planned sale
2,520 -2.0%
493.29
US$1,243,091 		2,520 -2.0% 493.29 US$1,243,091
2026-03-03 2026-02-27
PlS Planned sale
949 -0.7%
491.30
US$466,244 		949 -0.7% 491.30 US$466,244
2026-03-03 2026-02-27
PlS Planned sale
2,725 -2.1%
490.54
US$1,336,722 		2,725 -2.1% 490.54 US$1,336,722
2026-03-03 2026-02-27
PlS Planned sale
460 -0.3%
489.32
US$225,087 		460 -0.3% 489.32 US$225,087
2026-03-03 2026-02-27
PlS Planned sale
3,278 -2.4%
488.27
US$1,600,549 		3,278 -2.4% 488.27 US$1,600,549
2026-03-03 2026-02-27
PlS Planned sale
2,510 -1.8%
487.13
US$1,222,696 		2,510 -1.8% 487.13 US$1,222,696
2026-03-03 2026-02-27
PlS Planned sale
240 -0.2%
482.84
US$115,882 		240 -0.2% 482.84 US$115,882
2026-03-03 2026-02-27
PlS Planned sale
120 -0.1%
481.50
US$57,780 		120 -0.1% 481.50 US$57,780
2026-03-03 2026-02-27
PlS Planned sale
400 -0.3%
479.75
US$191,900 		400 -0.3% 479.75 US$191,900
2026-02-27 2026-02-27
PrS Proposed sale
40,000
493.47
US$19,738,905 		40,000 493.47 US$19,738,905
2025-08-07 2025-08-06
B Purchase
5,710 +5.2%
389.95
US$2,226,614 		5,710 +5.2% 389.95 US$2,226,614
2025-08-07 2025-08-06
B Purchase
4,290 +4.0%
389.08
US$1,669,153 		4,290 +4.0% 389.08 US$1,669,153
2024-11-12 2024-11-08
PlS Planned sale
15,198 -16.7%
515.00
US$7,826,970 		15,198 -16.7% 515.00 US$7,826,970
2024-11-08 2024-11-08
PrS Proposed sale
15,198
515.00
US$7,826,970 		15,198 515.00 US$7,826,970
2024-08-01 2024-07-30
PlS Planned sale
15,202 -14.3%
505.00
US$7,677,010 		15,202 -14.3% 505.00 US$7,677,010
2024-07-30 2024-07-30
PrS Proposed sale
15,202
505.00
US$7,677,010 		15,202 505.00 US$7,677,010
2024-07-24 2024-07-22
PlS Planned sale
15,202 -12.5%
497.00
US$7,555,394 		15,202 -12.5% 497.00 US$7,555,394
2024-07-22 2024-07-22
PrS Proposed sale
15,202
497.00
US$7,555,394 		15,202 497.00 US$7,555,394
2024-05-29 2024-05-24
PlS Planned sale
1,565 -1.3%
457.00
US$715,205 		1,565 -1.3% 457.00 US$715,205
2024-05-24 2024-05-24
PrS Proposed sale
1,565
457.00
US$715,205 		1,565 457.00 US$715,205
2024-05-22 2024-05-20
PlS Planned sale
15,202 -11.1%
447.00
US$6,795,294 		15,202 -11.1% 447.00 US$6,795,294
2024-05-20 2024-05-20
PrS Proposed sale
15,202
447.00
US$6,795,294 		15,202 447.00 US$6,795,294
2023-12-19 2023-12-15
PlS Planned sale
17,135 -13.6%
407.00
US$6,973,945 		17,135 -13.6% 407.00 US$6,973,945
2023-12-15 2023-12-15
PrS Proposed sale
17,135
407.00
US$6,973,945 		17,135 407.00 US$6,973,945
2023-12-15 2023-12-13
PlS Planned sale
5,098 -4.5%
397.00
US$2,023,906 		5,098 -4.5% 397.00 US$2,023,906
2023-12-13 2023-12-13
PrS Proposed sale
5,098
397.00
US$2,023,906 		5,098 397.00 US$2,023,906
2023-11-15 2023-11-13
PlS Planned sale
5,097 -4.3%
377.00
US$1,921,569 		5,097 -4.3% 377.00 US$1,921,569
2023-11-13 2023-11-13
PrS Proposed sale
5,097
377.00
US$1,921,569 		5,097 377.00 US$1,921,569
2023-07-18 2023-07-17
PlS Planned sale
7,828 -6.2%
355.00
US$2,778,940 		7,828 -6.2% 355.00 US$2,778,940
2023-07-17 2023-07-17
PrS Proposed sale
7,828
355.00
US$2,778,940 		7,828 355.00 US$2,778,940
2023-05-01 2023-04-27
PlS Planned sale
38 -0.0%
340.19
US$12,927 		38 -0.0% 340.19 US$12,927
2023-05-01 2023-04-27
PlS Planned sale
1,668 -1.3%
339.43
US$566,169 		1,668 -1.3% 339.43 US$566,169
2023-05-01 2023-04-27
PlS Planned sale
1,611 -1.2%
338.69
US$545,630 		1,611 -1.2% 338.69 US$545,630
2023-04-27 2023-04-27
PrS Proposed sale
3,317
339.08
US$1,124,735 		3,317 339.08 US$1,124,735
2023-01-27 2023-01-25
PlS Planned sale
10,000 -10.0%
315.05
US$3,150,500 		10,000 -10.0% 315.05 US$3,150,500
2022-08-17 2022-08-15
PlS Planned sale
11,689 -10.5%
305.06
US$3,565,846 		11,689 -10.5% 305.06 US$3,565,846
2022-06-28 2022-06-24
PlS Planned sale
11,689 -9.5%
291.30
US$3,405,006 		11,689 -9.5% 291.30 US$3,405,006
2020-08-10 2020-08-06
PlS Planned sale
93 -0.3%
273.27
US$25,414 		93 -0.3% 273.27 US$25,414
2020-08-10 2020-08-06
PlS Planned sale
487 -1.8%
272.76
US$132,834 		487 -1.8% 272.76 US$132,834
2020-08-10 2020-08-06
PlS Planned sale
471 -1.7%
271.42
US$127,839 		471 -1.7% 271.42 US$127,839